Literature DB >> 26690853

Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.

Bruna Gonçalves1, Carina Ferreira1, Carlos Tiago Alves1, Mariana Henriques1, Joana Azeredo1, Sónia Silva1.   

Abstract

Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. Although Candida albicans is the main cause of VVC, the identification of non-Candida albicans Candida (NCAC) species, especially Candida glabrata, as the cause of this infection, appears to be increasing. The development of VVC is usually attributed to the disturbance of the balance between Candida vaginal colonization and host environment by physiological or nonphysiological changes. Several host-related and behavioral risk factors have been proposed as predisposing factors for VVC. Host-related factors include pregnancy, hormone replacement, uncontrolled diabetes, immunosuppression, antibiotics, glucocorticoids use and genetic predispositions. Behavioral risk factors include use of oral contraceptives, intrauterine device, spermicides and condoms and some habits of hygiene, clothing and sexual practices. Despite a growing list of recognized risk factors, much remains to be elucidated as the role of host versus microorganisms, in inducing VVC and its recurrence. Thus, this review provides information about the current state of knowledge on the risk factors that predispose to VVC, also including a revision of the epidemiology and microbiology of VVC, as well as of Candida virulence factors associated with vaginal pathogenicity.

Entities:  

Keywords:  Behavioral factors; Candida species; host factors; vaginal infection; virulence factors

Mesh:

Year:  2015        PMID: 26690853     DOI: 10.3109/1040841X.2015.1091805

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  111 in total

1.  Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.

Authors:  Leighann Sherry; Ryan Kean; Emily McKloud; Lindsay E O'Donnell; Rebecca Metcalfe; Brian L Jones; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 2.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

3.  Retrospective Analysis of Candida-related Conditions in Infancy and Early Childhood Caries.

Authors:  Joanie Jean; Sara Goldberg; Ritu Khare; L Charles Bailey; Christopher B Forrest; Evlambia Hajishengallis; Hyun Koo
Journal:  Pediatr Dent       Date:  2018-03-15       Impact factor: 1.874

4.  The Vaginal Microbiota and Behavioral Factors Associated With Genital Candida albicans Detection in Reproductive-Age Women.

Authors:  Sarah E Brown; Jennifer A Schwartz; Courtney K Robinson; D Elizabeth OʼHanlon; L Latéy Bradford; Xin He; Katrina S Mark; Vincent M Bruno; Jacques Ravel; Rebecca M Brotman
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

5.  In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans.

Authors:  Andrew T Nishimoto; Nathan P Wiederhold; Stephanie A Flowers; Qing Zhang; Steven L Kelly; Joachim Morschhäuser; Christopher M Yates; William J Hoekstra; Robert J Schotzinger; Edward P Garvey; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

6.  Educating Patients on Unnecessary Antibiotics: Personalizing Potential Harm Aids Patient Understanding.

Authors:  Benjamin J Miller; Kathryn A Carson; Sara Keller
Journal:  J Am Board Fam Med       Date:  2020 Nov-Dec       Impact factor: 2.657

7.  Formulation, Pharmacological Evaluation, and Efficacy Studies of Occidiofungin, a Novel Antifungal.

Authors:  Akshaya Ravichandran; Jerome Escano; Jung Hwa Lee; Matthew K Ross; Frank Austin; Ravi Orugunty; Shi-En Lu; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

8.  Antimicrobial photodynamic therapy as a new approach for the treatment of vulvovaginal candidiasis: preliminary results.

Authors:  Maria Eugênia Simões Onofre de Santi; Renato Araujo Prates; Cristiane Miranda França; Rúbia Garcia Lopes; Aline Silva Sousa; Luis Rodolfo Ferreira; Sandra Kalil Bussadori; Adjaci Uchoa Fernandes; Alessandro Melo Deana
Journal:  Lasers Med Sci       Date:  2018-06-21       Impact factor: 3.161

9.  Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.

Authors:  Jian Miao; Hubertine M E Willems; Brian M Peters
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

10.  Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors.

Authors:  Chintan V Dave; Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Diabetes Obes Metab       Date:  2018-10-11       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.